Podcasts about survivorship

What if our obsession with “dangerous” sun is killing us?If you (recklessly) leave your urban office for lunch, you are told to yank your hat down low. If you (again, recklessly) let your kids dash into the backyard, you are told to slather them in sunscreen—or learn to live with the guilt.And yes, sun avoidance undoubtedly prevents some skin cancers, including the deadliest type, melanomaBut a recent study suggests sunlight contributes to hundreds of thousands of deaths every year in the United States alone—orders of magnitude more than the estimated 8400 annual US melanoma deaths.In this episode, we discuss evidence linking sun avoidance toalmost a million annual deaths in the US and Europe alone, exceeding the number caused by global military conflictsbreast, pancreatic, colon, and lung cancers, as well as heart disease, high blood pressure, and stroketo INCREASED risk of death in those diagnosed with sun-induced melanoma.Yes, you read that right; some melanoma deaths may be related to too little sunlight.  (But do understand that this is complex--sunlight DOES cause melanoma. Well, some melanomas....)We also discuss why supplementing with vitamin D pills fails to remedy these terrible conditions, and what a thoughtful person can do instead, while staying safe.We hope you enjoy this episode, and that it helps you enjoy the sun again--thoughtfully, of course. References and further reading:  Sunlight: Time for a Rethink?Benefits of oral Polypodium leucotomas extract in MM high risk patients (This is an ingredient in Life Extension's Shade Factor, mentioned in this episode by Dr. Gordon). Uses of Polypodium leucotomos Extract in Oncodermatology  Calzari et alInsufficient Sun Exposure Has Become a Real Public Health Problem. Alfredsson L, Armstrong BK, Butterfield DA, et al. International Journal of Environmental Research and Public Health. 2020;17(14):E5014. doi:10.3390/ijerph17145014.Prospective Study of Ultraviolet Radiation Exposure and Risk of Cancer in the United States. Lin SW, Wheeler DC, Park Y, et al. International Journal of Cancer. 2012;131(6):E1015-23. doi:10.1002/ijc.27619.An Estimate of Premature Cancer Mortality in the U.S. Due to Inadequate Doses of Solar Ultraviolet-B Radiation. Grant WB. Cancer. 2002;94(6):1867-75. doi:10.1002/cncr.10427.Solar Ultraviolet-B Exposure and Cancer Incidence and Mortality in the United States, 1993-2002. Boscoe FP, Schymura MJ. BMC Cancer. 2006;6:264. doi:10.1186/1471-2407-6-264.Ecological Studies of the UVB-vitamin D-Cancer Hypothesis. Grant WB. Anticancer Research. 2012;32(1):223-36.Sunlight Exposure in Association With Risk of Lymphoid Malignancy: A Meta-Analysis of Observational Studies. Kim HB, Kim JH. Cancer Causes & Control : CCC. 2021;32(5):441-457. doi:10.1007/s10552-021-01404-6.Adulthood Residential Ultraviolet Radiation, Sun Sensitivity, Dietary Vitamin D, and Risk of Lymphoid Malignancies in the California Teachers Study. Chang ET, Canchola AJ, Cockburn M, et al. Blood. 2011;118(6):1591-9. doi:10.1182/blood-2011-02-336065.Is Prevention of Cancer by Sun Exposure More Than Just the Effect of Vitamin D? A Systematic Review of Epidemiological Studies. van der Rhee H, Coebergh JW, de Vries E. European Journal of Cancer (Oxford, England : 1990). 2013;49(6):1422-36. doi:10.1016/j.ejca.2012.11.001.An Ecologic Study of Cancer Mortality Rates in Spain With Respect to Indices of Solar UVB Irradiance and Smoking. Grant WB. International Journal of Cancer. 2007;120(5):1123-8. doi:10.1002/ijc.22386.Does Sunlight Prevent Cancer? A Systematic Review. van der Rhee HJ, de Vries E, Coebergh JW. European Journal of Cancer (Oxford, England : 1990). 2006;42(14):2222-32. doi:10.1016/j.ejca.2006.02.024.Heliovaccination: Solar mediated immunity against cancer. Uzoigwe CE. Experimental Dermatology. 2020;29(5):477-480. doi:10.1111/exd.14087.Beneficial Health Effects of Ultraviolet Radiation: Expert Review and Conference Report. Riedmann U, Dibben C, de Gruijl FR, et al. Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology. 2025;24(6):867-893. doi:10.1007/s43630-025-00743-6.A Blueprint for the Primary Prevention of Cancer: Targeting Established, Modifiable Risk Factors. Gapstur SM, Drope JM, Jacobs EJ, et al. CA: A Cancer Journal for Clinicians. 2018;68(6):446-470. doi:10.3322/caac.21496.Proportion and Number of Cancer Cases and Deaths Attributable to Potentially Modifiable Risk Factors in the United States, 2019. Islami F, Marlow EC, Thomson B, et al. CA: A Cancer Journal for Clinicians. 2024 Sep-Oct;74(5):405-432. doi:10.3322/caac.21858.Cutaneous Melanoma. Joshi UM, Kashani-Sabet M, Kirkwood JM. JAMA. 2025;334(23):2113-2125. doi:10.1001/jama.2025.13074.Sunlight, Vitamin D and the Prevention of Cancer: A Systematic Review of Epidemiological Studies. van der Rhee H, Coebergh JW, de Vries E. European Journal of Cancer Prevention : The Official Journal of the European Cancer Prevention Organisation (ECP). 2009;18(6):458-75. doi:10.1097/CEJ.0b013e32832f9bb1.Lessons Learned From Paleolithic Models and Evolution for Human Health: A Snap Shot on Beneficial Effects and Risks of Solar Radiation. Reichrath J. Advances in Experimental Medicine and Biology. 2020;1268:3-15. doi:10.1007/978-3-030-46227-7_1.PS-Vitamin D. American Academy of Dermatology (2022).American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity. Kushi LH, Byers T, Doyle C, et al. CA: A Cancer Journal for Clinicians. 2006;56(5):254-81; quiz 313-4. doi:10.3322/canjclin.56.5.254.Vitamin D, Sunlight and Cancer Connection. Holick MF. Anti-Cancer Agents in Medicinal Chemistry. 2013;13(1):70-82.Survivorship. National Comprehensive Cancer Network. Updated 2026-04-08.Keratinocyte Carcinoma. Wehner MR. JAMA. 2025;:2840731. doi:10.1001/jama.2025.18749.Public Awareness and Behaviour in Great Britain in the Context of Sunlight Exposure and Vitamin D: Results From the First Large-Scale and Representative Survey. Burchell K, Rhodes LE, Webb AR. International Journal of Environmental Research and Public Health. 2020;17(18):E6924. doi:10.3390/ijerph17186924.Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement. US Preventive Services Task Force, Grossman DC, Curry SJ, et al. JAMA. 2018;319(11):1134-1142. doi:10.1001/jama.2018.1623.Lifetime Sunburn Trajectories and Associated Risks of Cutaneous Melanoma and Squamous Cell Carcinoma Among a Cohort of Norwegian Women. Lergenmuller S, Rueegg CS, Perrier F, et al. JAMA Dermatology. 2022;158(12):1367-1377. doi:10.1001/jamadermatol.2022.4053.Cancer Prevention and Early Detection Facts & Figures. Rick Alteri, Deana Baptiste, Emily Butler Bell, et al. American Cancer Society (2025). Skin Cancer, Irradiation, and Sunspots: The Solar Cycle Effect. Valachovic E, Zurbenko I. BioMed Research International. 2014;2014:538574. doi:10.1155/2014/538574.Intense Solar Activity Reduces UrinarDawn Lemanne, MD Oregon Integrative OncologyLeave no stone unturned.Deborah Gordon, MDNorthwest Wellness and Memory CenterBuilding Healthy Brains

Dr. Tyler Severance is a pediatric hematologist-oncologist at University of Missouri Healthcare, which means he works with kids who have blood and cancer disorders. He spoke about some of the short and long-term impacts cancer treatment can have on kids

Tim McDonald was sitting down for Thanksgiving dinner in 2020 when the pain started. A few days later, a doctor handed him a single sheet of paper and said three words nobody wants to hear: "You have cancer."Stage 4 colorectal cancer. Liver covered in tumors. A second oncologist told him he had three years to live and she'd focus on "quality of life." His response? "That's your story. Not mine."In this episode, Tim shares how over a decade of mindfulness practice shaped the way he faced one of the hardest diagnoses a person can receive and how he went from following doctors' orders to becoming the general manager of his own care team, ultimately pursuing a liver transplant at a time when fewer than 20 people in the US had received one for colorectal cancer.This conversation goes deep on:→ What it actually feels like to hear "you have cancer" and stay calm→ Why getting a second (and third, and tenth) opinion saved his life→ The player → quarterback → general manager framework for owning your treatment→ Men, vulnerability, and why cancer support groups changed everything→ The dark thought he had toward the end of chemo — and what pulled him back→ Why survivorship was mentally harder than treatment itself→ How advocacy work became part of his healingIf you or someone you love is navigating a cancer diagnosis, this episode is essential listening.───────────────────────────

Surviving breast cancer is only the beginning. For many survivors, the emotional, mental, and physical healing continues long after treatment ends.In this episode, Jamie sits down with Crystal Yang, RN, Board Certified Nurse Coach and co-founder of Perky, to explore the often-overlooked challenges of survivorship. Crystal shares how nurse coaching provides a safe, supportive space for breast cancer survivors to process life after treatment, navigate identity shifts, improve relationships, prioritize their well-being, and create a personalized path toward healing.Whether you're struggling with loss of identity, intimacy, anxiety, lifestyle changes, or simply wondering, "What's next?" after treatment, this conversation offers hope and practical guidance.In this episode, you'll learn:What nurse coaching is and how it differs from therapyWhy survivorship can be one of the hardest parts of the breast cancer journeyHow coaching empowers survivors to take ownership of their health and well-beingThe importance of being truly seen and heardHow Perky is helping survivors not just survive, but thriveConnect with Crystal Yang & PerkyWebsitehttps://helloperky.comBook Your Complimentary Discovery Coaching Sessionhttps://helloperky.com/nursecoachingPhone(210) 712-9765Emailcrystal@helloperky.comInstagram@weareperkyListen to Our Previous Conversation with PerkyIf you haven't listened to my first conversation with Crystal and Courtney from Perky, be sure to check it out!YouTube:https://youtu.be/2sIOeeAV_Hc?si=XJoGZILW4j0t54o2▶️ Watch the previous Perky episode on YouTubeIf this episode encouraged you, please subscribe, leave a review, and share it with someone navigating life after breast cancer. Every conversation helps bring hope, healing, and education to more survivors.Remember: Early detection saves lives. Healing doesn't end when treatment does.

DEAR PAO: Applying for survivorship pension at the Social Security System | July 7, 2026Subscribe to The Manila Times Channel - https://tmt.ph/YTSubscribe Visit our website at https://www.manilatimes.net Follow us: Facebook - https://tmt.ph/facebook Instagram - https://tmt.ph/instagram Twitter - https://tmt.ph/twitter DailyMotion - https://tmt.ph/dailymotion Subscribe to our Digital Edition - https://tmt.ph/digital Check out our Podcasts: Spotify - https://tmt.ph/spotify Apple Podcasts - https://tmt.ph/applepodcasts Amazon Music - https://tmt.ph/amazonmusic Deezer: https://tmt.ph/deezer Stitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tunein#TheManilaTimes#KeepUpWithTheTimes Hosted on Acast. See acast.com/privacy for more information.

In Part 2, Christopher Cogle examines the long-term realities facing cancer survivors. From vaccine hesitancy and quality-of-life disparities to healthcare access and survivorship policy, this episode explores how systems can better support patients beyond active treatment.  Timestamps:  00:50 – Vaccine hesitancy  04:33 – QoL after cancer  07:30 – Policy support   11:10 – Survivorship care 

What does it actually mean to advocate for yourself in the medical system?Dr. Holly Lucille, ND, RN, ONC sat down with Dr. Tina Kaczor for a candid conversation about helping patients access the best possible care through self-advocacy and shared decision-making.Navigating a cancer diagnosis is incredibly overwhelming. Between well-intentioned opinions from loved ones and rushed informed consent, it's easy to feel lost. Dr. Lucille brings compassion and pragmatism to the table, explaining why we need to slow down, understand the true risks and side effects, and look at the whole picture—physical, emotional, and spiritual.In this episode:The Power of Slowing Down: How to navigate a new diagnosis without being rushed into decisions.The Myth of "Forced Positivity": Breaking down the toxicity of societal pressure to stay positive.Holistic Resilience: The impact of adverse childhood experiences (ACEs), relationships, and the practice of habitual nourishment.Healing Tools that Work: A look at trauma-informed strategies like EMDR, brainspotting, and the role of spirituality in recovery.Want to learn more about Dr. Lucille? Visit her website.Leave a message and let us know what you liked about the episode!Support the showBecome a member of The Cancer Pod Community! Gain access to live Q&As, exclusive content, and so much more! Join us today on Buy Me a Coffee or on Patreon!Check out our website! Looking for more information? We have blogs, merch, and all of our episodes listed by season and category. Shop our favorite reads! We've joined with Bookshop.org to offer some of our fave books!Buy our merch! Whether it's a cozy hoody or a handy water bottle, we have something for everybody.Have a comment or suggestion? Email us at info (at) thecancerpod (dot) com Follow us wherever you browse. We're always @TheCancerPod:InstagramBlueskyFacebookLinkedInYouTubeTHANK YOU!!

Farla Efros is a senior retail executive and former CEO who built and sold companies before facing her own breast cancer diagnosis. She brings that same operational mindset into a healthcare system that expects patients to manage complexity while they are at their most vulnerable.She was on a client call in Spain when the diagnosis came through. A clear mammogram had missed it. An MRI caught it. Within hours, she was ordering binders, building a plan, and structuring her treatment like a turnaround strategy. Every appointment became a meeting. Every doctor faced an agenda with dozens of questions. She paid out of pocket for PET scans that were denied and hired a third party firm to validate her treatment path when her own doctors resisted outside input. The conversation tracks what happens when a high-functioning executive enters a system built on delay, denial, and fragmentation. Efros describes negotiating for tests, managing physician relationships, and assembling an “executive board” of advisors across conventional and alternative care. She calls the experience “the worst client I ever had,” exposing how administrative burden shifts onto patients and families.The tension sits between what worked for her and what is inaccessible to most. Her approach requires confidence, time, and fluency in navigating power. The system rewards that behavior while quietly failing patients who cannot replicate it. Insurance coverage still left her paying out of pocket. Doctors pushed standard protocols over precision medicine. Survivorship offered little support once treatment ended.This episode examines how cancer care operates as a series of incentives rather than a coordinated system, and why patients are forced to become operators just to get through it.RELATED LINKSFarla EfrosFarla Efros on LinkedInF*ck CancerF*ck Cancer on AmazonAccentureCTOAMPULL QUOTES“I treated cancer like the worst client I ever had.”“They wouldn't approve the test, so I paid for it myself.”“Every appointment was a negotiation.”FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The MLB owner proposal to restructure the draft — including eliminating the high school portion and shrinking the minor leagues — landed last week. The reaction across the baseball internet was the usual reflexive "negative." This episode is the case for the other side, and it lands on a thesis BSGB has been building toward for two years: college baseball's player development resources are underrated, and the loudest criticisms don't hold up against the data.Trevor and Dan walk the proposal piece by piece, then spend the back half breaking down why college dev is the better environment for almost every prospect not named Konnor Griffin.The thesis arc:Cost-saving for cost-saving's sake (capped bonus pools, eliminated rounds) gets a flagCutting minor league teams to reinvest in the ones that remain gets a thumbs-upThe high school draft elimination is the heart of the conversationThe "college coaches don't care about development" take gets dismantledThe "minor leagues are safer because of pitch counts" take gets dismantledThe actual proof: Skenes, Lowder, Chase Burns, Nick Kurtz — each one built inside a college programThe injury prevention edge: programs running NewtForce mounds with integrated biomechanics flag the risk before the pitcher feels it (vs. a road-trip start in low-A with no data infrastructure)The trickle-up reality: spin metrics, high-ride fastballs, every "new" thing the MLB broadcasters discover — college was running it two years earlierThe coach reality: Wes Johnson, Matt Hobbs, Dan Heefner are at college programs because that's where the development happens, the resources are, and the pay matchesWhy people get this wrong:Survivorship bias. The Konnor Griffin and Jackson Holiday cases are real — they're also unicorns. The kids most baseball fans never name — Riley Pint, Lonnie White, the Guardians' "million-dollar outfield" — got drafted out of high school for seven figures and never sniffed the big leagues. Two years of high-level college baseball would have given them a shot at maturity, an education, a fallback, and a more developmental environment than the bus to Jackson, Mississippi.Why college player dev is actually better:Tech parity (or surplus) vs. an MLB org's minor-league systemTop coaches making more in college than they would as pro pitching coordinatorsIntegrated biomech + ground-force + bullpen data layers inside the buildingCoach access (Matt Hobbs, Dan Heifner, Wes Johnson) for direct daily repsEducation + maturity layer that no minor league system can replicateWhy this matters:The MLB owner proposal is a starting point, not a contract. But the premise that college baseball can absorb more of the development pipeline — especially with NIL paying these kids real money to stay — is on extremely solid ground. The case Trevor and Dan lay out here is the cleanest defense of college player development BSGB has done on the pod.00:00 Intro · Take Two (Wi-Fi-Loss Edition) 01:30 The Gym Streak + Sunday Move Day 09:30 The MLB Draft Restructuring Proposal 10:30 What's Good · Reinvesting in the Minors 13:30 What's Bad · Capping Free-Agent Bonus Pools 16:00 The High School Draft Conversation 19:30 Survivorship Bias · Riley Pint, Million-Dollar Outfield 23:00 College Player Development, Underrated 27:30 The Tech Offsets the Pitch Count 30:30 Skenes, Lowder, Burns, Kurtz · The Proof 35:00 Player Dev Trickles UP, Not Down 38:00 Injury Prevention Tech in College 41:00 The Coaching Reality · Wes, Hobbs, Heefner 45:00 Why Pro Coordinators Get Paid Less Than College Assistants 48:30 Recruiting + Roster Spots · The Transfer Pushback 53:00 The Education Layer + NIL 56:30 The International Draft Conversation 1:00:00 What People Get Wrong About College Baseball 1:04:00 Closing · The Game Wins If This Goes Through

In this second part of TOGA's Conversations in Lung Cancer Research two-episode series, A/Prof Adnan Nagrial, a Medical Oncologist at Westmead Hospital, leads a panel discussing the clinical implications of the March 1st broad Pharmaceutical Benefits Scheme (PBS) listing of ipilimumab and nivolumab in Australia. Joined by Prof Nick Pavlakis (Senior Staff Specialist at Royal North Shore Hospital, Professor of Medicine at the University of Sydney, former chair of TOGA), Dr. Sam Bowyer (Medical Oncologist at Sir Charles Gairdner Hospital and Clinical Researcher at Linear Clinical Research) and Dr. Lavinia Tan (Medical Oncologist at Peter MacCallum Cancer Centre), the conversation explores how this newly granted flexibility alters treatment paradigms across various thoracic malignancies, including non-small cell lung cancer (NSCLC), mesothelioma, small cell lung cancer (SCLC), and rare thymic tumours while also addressing toxicity management and the growing demands of patient survivorship. Podcast Sponsor Note: This podcast was proudly sponsored by Bristol Myers Squibb. All development and editorial decisions were made independently by the speakers. (00:00) Welcome and Acknowledgement (01:33) Panel Introductions (02:52) First Reactions in Clinic (05:01) Frontline NSCLC Evidence (06:48) Who Gets Ipi Nivo? (11:29) Chemo Free and Rechallenge (15:20) Stopping or Continuing IO (20:34) Mesothelioma Treatment Choices (27:20) Small Cell Reality Check (30:21) Thymic Malignancies Debate (34:54) Governance and Toxicity Safety (38:44) Survivorship and Follow Up (43:43) Real World Data Next Steps (48:05) Wrap Up Support TOGAThank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify.---------------Connect with TOGAAttend an Event: https://thoraciconcology.org.au/events/Become a Member: Join the TOGA community at https://thoraciconcology.org.au/membership/Donate: Support our research and treatment initiatives at https://thoraciconcology.org.au/support-us/donate/Follow UsLinkedIn: https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/X (Twitter): https://x.com/TOGAANZInstagram: https://www.instagram.com/togaanz/YouTube: https://www.youtube.com/@Thoracic_Oncology---------------Acknowledgement of CountryThe Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Though cheap surgery overseas sounds like the ultimate life hack, Nick Pell takes a scalpel to the potential perils of medical tourism on Skeptical Sunday.Welcome to Skeptical Sunday, a special edition of The Jordan Harbinger Show where Jordan and a guest break down a topic that you may have never thought about, open things up, and debunk common misconceptions. This time around, we're joined by writer and researcher Nick Pell!Full show notes and resources can be found here: jordanharbinger.com/1348On This Week's Skeptical Sunday:How the "ultimate life hack" hides a brutal trade-off. Flying abroad for a 70% discount on a medical procedure means leaving behind malpractice law, insurance, and safety oversight. The money you save is often the safety net you lose, with no undo button and no legal recourse when something goes wrong.Why medical tourism brokers act more like salesmen than surgeons. Anyone can call themselves a "facilitator" with zero licensing, then pocket 10 to 40 percent commissions for steering you toward the highest-paying clinic rather than the cleanest one, often with an influencer doing the marketing.What the glossy recovery photos leave out. Survivorship bias buries the waterborne infections, wounds that won't close, and fatal embolisms. BBLs are the deadliest cosmetic procedure on record, and many botched jobs land back in US ERs, where your premiums quietly cover the six-figure repair.Why the darkest edge of this market runs on organ harvesting. Chinese sites promise new kidneys in weeks, a timeline that's biologically impossible unless you know when a donor will die. Investigators tie it to forced harvesting from Falun Gong and Uyghur detainees treated as living spare parts.How to vet a clinic before you book the flight. Start with CDC medical tourism alerts, confirm JCI or ISAPS accreditation, and verify the surgeon's license on an official government registry. Insist on hospital admitting privileges, and budget two to four weeks of recovery before flying home.Connect with Jordan on Twitter, Instagram, and YouTube. If you have something you'd like us to tackle here on Skeptical Sunday, drop Jordan a line at jordan@jordanharbinger.com and let him know!And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors: Zazzle: 25% off first order: Zazzle.com ConciergeMD: 20% off all services/memberships: conciergemdla.com/jordan, code JORDANSimpliSafe Home Security: 50% off + 1st month free: simplisafe.com/jordanWhatnot: Start selling today: whatnot.com/sellSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us Fan MailAdjusting to life after a cancer diagnosis goes well beyond the initial treatment. Survivors adjust to a new normal that requires a comprehensive support plan and team to help them navigate survivorship. In this episode, Kimmie Carney, RN, care coordinator at the Nassif Community Cancer Center, joins Dr. Arnold to discuss survivorship support.For more information, call the Community Cancer Center at (319) 558-4876 or visit communitycancercenter.org/survivorship. If you have a topic you'd like Dr. Arnold to discuss with a guest on the podcast, shoot us an email at stlukescr@unitypoint.org.

On June 12, 2026, Elon Musk officially became the world's first trillionaire after SpaceX's record-shattering IPO. But here's the uncomfortable part: he built that fortune by breaking the most repeated rule in personal finance. He never diversified. He bet everything — twice — on companies he controlled. In this episode, I unpack what that actually means for your money. We walk through Musk's all-in playbook, from the $180 million PayPal payout to nearly going broke in 2008, and confront an uncomfortable truth: nobody ever got on the Forbes list with a diversified portfolio. Then we visit the graveyard nobody talks about — the thousands who made the same bet and lost everything — and break down the three advantages Musk had that you and I don't. You'll leave with a clear framework: when concentration makes sense, when diversification is non-negotiable, the one concentrated bet you already own (and should double down on), and how to size a "conviction bet" without putting your family's plan at risk. What we cover: The SpaceX IPO and what a trillion dollars actually looks like. The all-in playbook: PayPal to near-bankruptcy to history. Why diversification will never make you rich — and isn't supposed to. Survivorship bias: Enron, dot-com, and the losing tickets history forgets. Concentrate to build, diversify to keep: what this means for you Questions about your own portfolio's hidden concentration? Book a conversation by emailing me at info@creatingricherlives.com. Disclosure: This episode is for educational purposes only and is not personalized investment advice.

Today on National Cancer Survivor's Day, we're joined by a remarkable performer whose strength, vulnerability, and resilience have inspired millions around the world. She has taken the stage as a backup vocalist for numerous top artists and most recently dazzled the crowds on the biggest tour in music history with global superstar Taylor Swift. However, audiences were moved even more deeply when she chose to publicly share something far more personal – her breast cancer journey. After Jeslyn Gorman's diagnosis become known through The Eras Tour docuseries, fans witnessed the emotional reality of navigating cancer while stepping away from a career and community she loves so deeply. From continuing to tour in the early days of diagnosis, to facing treatment side effects and returning to the stage immediately following treatment, her story is one of courage, grace and resilience. Today, Jeslyn opens up about the support she received, what survivorship looks like now and most importantly, shares an empowering message for young women about listening to their bodies, advocating for their health, and never underestimating the importance of early detection. Key Takeaways: Early detection can save lives. You can experience joy and fear at the same time. A strong support system makes a major difference. Recovery is gradual and requires patience. Cancer changes your life, but it doesn't define it. Chapters 00:00 – Jeslyn's Breast Cancer Diagnosis 05:24 – Continuing to Perform After Diagnosis 07:38 – Going Public With Her Cancer Story 13:22 – Breast Health and Self-Advocacy 18:07 – Support From Family, Friends, and the Tour Community 22:17 – Staying Positive During Treatment 25:17 – Chemotherapy and Physical Recovery 31:49 – Hair Loss and Identity Learn more at realpink.komen.org and komen.org Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship. 37:29 – Life After Treatment and Survivorship

“I mean, I believe so strongly that food, what we eat, matters.” —Jen NolanIn this episode of the Real Health Podcast, Dr. Michelle Niesley is joind by Jen Nolan, owner of Remission Nutrition and nutrition advisor at Riordan Clinic, to explore nutrition recomendations and the differences between what is recommended during active treatment and after treatment.

Send me a DM here (it doesn't let me respond), OR email me: imagineabetterworld2020@gmail.comToday I'm so honored to have back on the show once again: Non-binary, queer and polyfragmented cult torture, mind control, and incest survivor, overcomer and whistleblower living with Dissociative Identity Disorder, award winning published - and passionate - writer and author - writing the books they needed as a struggling teen and couldn't find, content creator, artist and visionary, entrepreneur, educator, and the brightest and most colorful light in this dark world: Cheryl Rainfield. A little bit about Cheryl if you missed their last episode or need a recap, as well as what you can expect to hear about in today's episode: Born in Toronto and raised in what appeared to be an ordinary middle-class family, Cheryl endured horrors few can fathom: intergenerational organized cult torture involving ritual abuse, mind control, trafficking, incest, and calculated programming designed to shatter body, mind, and soul. From birth—likely even in utero—the cults (interconnected KKK, Nazi, satanic, and Christian factions stretching back generations) subjected them to extreme torture, sexual violence, and psychological warfare in everyday places like church basements, forests, warehouses, and private homes. Yet even as a child, Cheryl found cracks in the darkness. Writing and art became their first lifelines, silent workarounds that allowed truth to slip past threats and programming. In their early teens, parts of their system began sharing memories, starting with incest. A school story written by one part reached a believing teacher, prompting police and child protective services involvement—a fragile first step toward light. But safety was not immediate. Cult-involved parents deployed a sabotaging therapist, and torture intensified. But Cheryl's system refused silence. At 15, they chose their own therapist—an extraordinary cult torture survivor with DID—who instantly recognized the switching and offered profound validation. Cheryl lives with polyfragmented DID: thousands of fragments forming complex hubs, subgroups, and inner worlds, some self-created for protection, others deliberately crafted by the cult. Escape was not one dramatic moment but a marathon of courage—layer by layer, memory by memory, through inner cooperation, unraveling programming, and building co-consciousness. It took most of their life, but they reached safety, proving freedom is possible no matter how long the road.Through it all, writing and art served as a sanctuary and superpower. Cheryl began pouring pain onto pages as soon as they could hold a pencil. In their late 20s and early 30s, they became the author they needed as a struggling teen—the one they couldn't find. Their award-winning books, including Scars (with Cheryl's own scarred arm on the cover), Stained, Hunted, and Visions, draw deeply from trauma and healing while delivering powerful literary fiction. Beyond the page, Cheryl's impact radiates through social media, articles, raw videos, podcasts, and art that illuminates cult torture, polyfragmented DID, mind control, and the path to wholeness.On Cheryl's last episode we did together, we explored their testimony in depth - I would highly encourage you to watch that episode before or after this one to be truly inspired by what Cheryl has lived through and overcome. On today's episode, we will be diving deeper into topics pertaining to Dissociative Identities - self and cult created, Dissociative Identity Disorder, cult abuse and torture, recovery, healing, creativity through art - and so much more. Cheryl is not only a survivor—they are a miracle in motion, a revolution of hope, and the brightest and most colorful light this world has ever seen. Their story is far from over. And because they chose to rise, countless others now know they can too. The future is brighter because Cheryl is here—and together, with hearts open and voices united, we are lighting up the world.Some Signs and Symptoms of Cult Torture and How To Help:-https://www.cherylrainfield.com/some-signs-and-symptoms-of-cult-torture-and-how-to-help/Articles on cult torture and programming:-https://www.cherylrainfield.com/articles-cult-abuse/Resources on cult torture and DID -https://www.cherylrainfield.com/links-healing/Books on cult torture/RAMCOA:-Becoming Yourself by Alison Miller-Healing The Unimaginable by Alison Miller-Demystifying Mind Control & Ritual Abuse -Safe Passage to Healing by Chrystine Oksana. It's out of print but you can still buy copies.Websites on cult torture: -Survivorship.org-ra-info.org -ritualabuse.us-endritualabuse.org-https://grassroots-ra-mc-collective.org/CONNECT WITH CHERYL:TT: https://www.tiktok.com/@cherylrainfieldIG: https://www.instagram.com/cherylrainfieldFB: https://www.facebook.com/cheryl.rainfield/YT: https://www.youtube.com/@Cheryl.Rainfield                                             Substack: https://substack.com/@cherylrainfieldSupport the show

Love the podcast? Send us a text!What happens when you give yourself one year to “get through breast cancer” — only to realize that the timeline is much longer and more complicated than you imagined?In this episode of Breast Cancer Conversations, I'm joined by Jessica Thomas, who was diagnosed with ER/PR-positive, stage 2B breast cancer with lymph node involvement. After finding a lump herself, Jessica moved through the overwhelming sequence of imaging, biopsies, chemotherapy, double mastectomy, radiation, reconstruction delays, implant complications, DIEP flap reconstruction, tamoxifen, and Verzenio.But as Jessica shares so honestly, one of the hardest parts was not only the treatment itself. It was the waiting: waiting for results, waiting for a plan, waiting to know what came next, and trying to live inside the uncertainty.This conversation is for anyone who has ever thought, “I just need a plan.” It is for anyone who has felt overwhelmed by the number of medications, appointments, side effects, and decisions that come with breast cancer. And it is especially for anyone who has reached the end of active treatment only to realize there is still so much more to navigate.Support the showListener FeedbackIf this episode resonated with you, we invite you to leave a review on Apple Podcasts or Spotify.You can also click the link in the show notes that says "Love this episode? Send us a text" to share feedback.Messages are completely anonymous.If you would like us to follow up directly, please include your email address in your message so we can respond.Latest News: Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources from SurvivingBReastCancer.org! Become a Breast Cancer Conversations+ Member! Sign Up Now. Enjoying our content? Please consider supporting our work. 

In this episode, we talk with Christy Donovan, DNP, RN, a Blood Cancer Coordinator at the the Blood and Marrow Transplant/ Leukemia Program at Northside Hospital Cancer Institute, about what survivorship really looks like after a stem cell transplant. The central message is that survivorship is not a finish line. It is a transition into a new normal. Many patients expect life to return to the way it was before diagnosis or transplant, but recovery usually feels slower, messier, and more emotional than that. Fatigue, side effects, fear, and frustration can last for months, and that does not mean something is wrong. It means recovery is still happening. We also focus on how important it is to set realistic expectations. Christy explains that early struggles do not define long term outcomes. A setback in the first weeks or months after transplant does not mean a patient will not go on to live a full and meaningful life. Recovery takes patience. Small wins matter. Walking to the mailbox, cooking a meal, or getting through a day with a little more energy can be major milestones. Over time, those moments add up. Another major theme is emotional recovery. We talk about the fear of recurrence and the challenge of learning what is normal after treatment versus what should be reported to a doctor. That education helps people feel more confident and less trapped by fear. We also touch on how easy it is to forget that some aches and pains may simply come with getting older, not always with cancer. That perspective can be grounding. Other survivors can be a valuable information resource, too. Support comes up again and again throughout the conversation. Caregivers remain important in survivorship, but their role changes. Friends, peer support, support groups, podcasts, and survivorship communities all help patients feel less isolated. Christy emphasizes the value of honesty and vulnerability, especially in telling people what kind of support is needed on a given day. Some days call for celebration. Some days call for rest. We also talk about the tension between wanting to get back to life and needing to stay safe. Many survivors ask when they can return to work, travel, attend church, or see family. That desire is a good sign. It shows hope. At the same time, it takes guidance from the healthcare team to know when and how to widen that protective bubble. The episode ends on a hopeful note. Christy shares that she does not think of one survivor story. She thinks of many faces. She describes the joy of seeing patients return months later looking stronger, brighter, and more like themselves. That image captures the heart of the episode. Survivorship is hard, but it is also full of possibility, growth, connection, and life after transplant. More: Northside Hospital Cancer Institute Blood & Marrow Transplant Program — https://www.northside.com/services/cancer-institute/cancer-treatment-options/blood-marrow-transplant-program Northside Hospital Cancer Institute Blood Cancer Program — https://www.northside.com/services/cancer-institute/cancer-programs/blood-cancer-program National Bone Marrow Transplant Link (nbmtLINK) — https://www.nbmtlink.org/ Thanks to this season's sponsors, Incyte and Sanofi. (00:00) Introduction (00:40) Meet Christy Donovan (01:42) Survivorship as a transition (03:00) The role of caregivers and support after transplant (03:38) Early struggles vs long term outcomes (05:41) Emotional impact and fear of recurrence (07:02) Learning what is normal and what is not (07:55) Support groups, healing arts, and community (08:44) Being honest with friends about what you need (09:34) Managing energy and celebrating small wins (11:02) Patience, hope, and finding your people (13:15) Common questions in early survivorship (14:27) Expanding the protective bubble (15:20) The many faces of survivorship (17:03) Final encouragement and close National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/Check out our valued nbmtLINK resource books, some for sale, some free as downloadable, https://www.nbmtlink.org/shop/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.This content is provided for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. It is crucial to consult directly with a qualified healthcare professional regarding any medical conditions, treatment options, or other health concerns.The views and opinions expressed by the speakers are their own and do not necessarily reflect the official policy or position of the nbmtLINK. Unless otherwise stated in an official policy, the nbmtLINK does not endorse any specific treatments, products, or services mentioned by the speakers. Reliance on any information provided is solely at your own risk.The Marrow Masters Podcast is produced by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Today, Peggy talks with Daniel Gaylor, LCSW, OSW-C, ACHP-SW, and a social work supervisor at Moffitt Cancer Center, about what happens after patients and caregivers get through the intense treatment period and begin asking, “Now what?” Daniel explains that recovery does not mean life snaps back to normal. Survivorship brings fear, relief, hope, uncertainty, and exhaustion all at once. Those reactions are normal, and they deserve to be named. Daniel explains why post-traumatic stress disorder (PTSD) can show up after transplant. A transplant is not a routine treatment. It can involve long hospital stays, isolation, major physical side effects, and real fears about survival. When patients return for follow up visits, they may be brought back emotionally to those difficult hospital days. This can make survivorship feel complicated, even when the transplant was successful. Another key theme is slowly letting go. Patients may feel afraid to go out, socialize, eat in a restaurant, drive, or return to activities they once enjoyed. Daniel encourages survivors to start small and to be fair to the situation. It is easy to imagine the worst case. But it also helps to keep yourself honest - say out loud what could happen if things go well. The episode also addresses the “strain of worry.” Daniel describes signs of anxiety and depression, including sleep problems, racing thoughts, trouble concentrating, irritability, sadness, appetite changes, and not wanting to do things that usually bring joy. He reminds listeners that difficult days do not mean failure. Survivors should be able to say, “Today is not my best day,” and ask for help. Peggy and Daniel also talk about toxic positivity. While loved ones often mean well, phrases like “you're lucky to be alive” can minimize a survivor's fear or pain. Daniel encourages honest communication. Patients can thank loved ones for their support while also explaining what would help more. Social connection is another major part of healing. Daniel urges survivors and caregivers to increase connection and reduce isolation. A quick text, a short call, a support group, or a shared conversation can make a real difference. Peggy highlights programs where survivors can meet others who understand graft versus host disease (GVHD) and transplant recovery. Daniel closes with the idea of building a “tool belt.” Each person needs practical coping tools, whether that is a friend, music, journaling, counseling, mindfulness, a book, or a favorite place to reset. Caregivers need their own tool belts too. Transplant affects the whole support system, and survivorship works best when people communicate, ask for help, and remember they are not meant to do this alone. Links: Elephants and Tea: https://elephantsandtea.org/ BMT InfoNet: https://bmtinfonet.org/ Blood Cancer United: https://bloodcancerunited.org/ Thanks to this season's sponsors, Incyte and Sanofi. (00:00) Intro (01:01) Normalizing emotional reactions during recovery (04:22) PTSD after transplant and why it matters (08:59) Slowly letting go after transplant (13:12) Facing the worst case and choosing to move forward (13:53) The strain of worry and mental health red flags (19:31) Toxic positivity and the power of validation (20:26) How to talk with loved ones who are trying to help (22:39) Social health, connection, and friendship (26:43) Support groups, GVHD, and feeling understood (28:07) Building a survivorship "tool belt" (33:08) Why transplant never fully “stops” (36:39) A patient story about resilience and asking for help National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/Check out our valued nbmtLINK resource books, some for sale, some free as downloadable, https://www.nbmtlink.org/shop/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.This content is provided for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. It is crucial to consult directly with a qualified healthcare professional regarding any medical conditions, treatment options, or other health concerns.The views and opinions expressed by the speakers are their own and do not necessarily reflect the official policy or position of the nbmtLINK. Unless otherwise stated in an official policy, the nbmtLINK does not endorse any specific treatments, products, or services mentioned by the speakers. Reliance on any information provided is solely at your own risk.The Marrow Masters Podcast is produced by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of Marrow Masters, Peggy Burkhard talks with caregiver Ashlee Cramer about what caregiving really looks like during cancer, bone marrow transplant, and survivorship. Ashlee shares the story of her son Michael, who was diagnosed in 2020 with hepatosplenic T-cell lymphoma. Their family had already lived through cancer once before, when Ashlee's husband Patrice was diagnosed with large B-cell lymphoma in 2014 and later died at home in hospice, surrounded by his family. Ashlee explains that caregiving is often misunderstood. Caregivers are not saints who always feel strong, positive, or ready. Many are scared, exhausted, grieving, and trying to manage jobs, children, finances, appointments, medications, and the emotional weight of watching someone they love suffer. She says caregivers often feel pressure to do everything alone, but that pressure can lead to burnout and isolation. The conversation focuses on the reality that caregiving is not always temporary or predictable. For Michael, treatment moved quickly from diagnosis to hospitalization to transplant. He received a stem cell transplant from an anonymous donor, went into remission, and then developed serious complications, including engraftment syndrome, acute graft versus host disease (GVHD) , and chronic GVHD. Ashlee says Michael is a miracle, and while GVHD remains part of his life, the key word is living. Ashlee also talks about mental health for caregivers. She names anxiety, depression, post-traumatic stress disorder (PTSD), burnout, and loneliness as common experiences. She points out that many cancer centers offer support for patients, but caregivers often have to search for help on their own. Support groups, virtual programs, and caregiver resources can make a major difference because connection helps people feel less alone. A central message of the episode is that caregivers need care too. Ashlee encourages caregivers to take small pockets of peace when they cannot take a full day away. A shower, a breathwork practice, a walk outside, a cup of coffee, or a short hug from another caregiver can help. She also reminds caregivers to accept help. A meal train, a friend waiting in the hospital lobby, or someone offering a few minutes of support can ease the load. The episode ends with hope. Ashlee talks about post-traumatic growth, or PTG, and the idea that people do not have to bounce back to who they were before trauma. They can bounce forward. Michael and Ashlee continue to advocate, share their story through their podcast Michael and Mom Talk Cancer, and remind other caregivers that they are not alone. Thanks to this season's sponsors, Incyte and Sanofi. (00:00 Intro (04:05) Misconceptions about caregiving and why caregivers are not saints (05:30) Why caregivers should not be expected to do everything alone (07:00) The pressure to “stay strong” and how it can isolate caregivers (09:49) The reality of caregiving and how much it affects mental health (12:03) Work, family, sacrifice, and the myth of balance (16:40) Caregiver anxiety, depression, PTSD, burnout, and the need for support (20:40) Finding small “pockets of peace” when a full break is impossible (23:10) What Ashlee wishes she knew earlier about speaking up and asking questions (24:59) Why accepting help matters and how a meal train supported her family (34:09) Post-traumatic growth and the idea of bouncing forward instead of bouncing back National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/Check out our valued nbmtLINK resource books, some for sale, some free as downloadable, https://www.nbmtlink.org/shop/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.This content is provided for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. It is crucial to consult directly with a qualified healthcare professional regarding any medical conditions, treatment options, or other health concerns.The views and opinions expressed by the speakers are their own and do not necessarily reflect the official policy or position of the nbmtLINK. Unless otherwise stated in an official policy, the nbmtLINK does not endorse any specific treatments, products, or services mentioned by the speakers. Reliance on any information provided is solely at your own risk.The Marrow Masters Podcast is produced by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Today, Peggy Burkhard talks with Dr. Amar Kelkar of the Dana-Farber Cancer Institute about the medical side of survivorship after bone marrow, stem cell, or CAR-T transplant. The conversation begins with the important shift from the urgent “save my life” phase to the longer “protect my health” phase. Dr. Kelkar explains that this transition often starts around the 100-day mark, though timing varies by transplant center, geographical region and patient needs. A major theme is the need to restart routine care that may have been paused during transplant. Dental care, dermatology, ophthalmology, and primary care all become important again. Dental visits are especially important because oral graft-versus-host disease (GVHD) can cause dry mouth, irritation, cavities, and other problems. Skin checks matter because transplant can increase the risk of skin cancers. Dr. Kelkar stresses annual dermatology visits, sun protection, SPF 50 or higher, protective clothing, and smart decisions about sun exposure. Fatigue is another central topic. Dr. Kelkar describes post-transplant fatigue as different from normal tiredness. It can feel deep, physical, and mental, and it may last for months or even years. He encourages patients to pace themselves, listen to their bodies, and build activity back slowly. Returning to work also needs to be individualized. Some patients work remotely during treatment, while others may need extended disability or a gradual return. The episode also covers immune recovery and repeat vaccinations. Dr. Kelkar explains that after transplant, the immune system has been reset, and many childhood vaccines need to be repeated. Most programs begin revaccination around six, nine, or 12 months, depending on immune suppression and other factors. He reassures listeners that many patients have fewer vaccine symptoms early on because their immune systems are still rebuilding. Dr. Kelkar also reviews long-term screening and prevention. Survivors need routine cancer screenings, including mammograms, colonoscopies, lung cancer screening when appropriate, skin exams, and monitoring for thyroid or other changes. Metabolic health is also important. Steroids can affect blood sugar, transplant can change body composition, and quick weight loss often includes muscle loss. Nutrition support and exercise programs can help, and Peggy notes that Blood Cancer United offers nutrition services for patients and caregivers. Blood Cancer United's nutrition program provides free one-on-one consultations with oncology dietitians by phone or email. Bone health, hormone changes, sexual health, and early aging are also discussed. Dr. Kelkar explains that steroids, menopause, testosterone changes, vitamin D deficiency, and time indoors can affect bones. Many centers use DEXA scans and vitamin D supplementation. He also encourages patients to bring up sexual health concerns, including menopause symptoms, low testosterone, pain with intercourse, ulcers, or fear about resuming intimacy. The episode closes with practical advice for everyday life. Food restrictions often loosen around 100 days, but patients should reintroduce foods slowly and carefully. Raw foods, alcohol, tobacco, and inhaled smoke should generally be avoided, especially during the first year. Dr. Kelkar also emphasizes mental health support, counseling, and honest conversations with the medical team. Survivorship is a bumpy road, but the goal is to help patients regain control and thrive. Blood Cancer United Nutrition Offerings: https://bloodcancerunited.org/blood-cancer-care/adults/food-nutrition Thanks to this season's sponsors, Incyte and Sanofi. (00:00) Intro (01:16) Moving from acute treatment to survivorship (02:17) Dental, dermatology, ophthalmology, and routine care (05:45) Fatigue after transplant versus normal tiredness (08:35) Pacing yourself and avoiding setbacks (10:26) Returning to work after transplant (12:24) Resetting the immune system and repeat vaccinations (16:07) Secondary malignancy prevention and cancer screenings (18:59) Sun protection and skin cancer prevention (20:23) Metabolic health, blood sugar, and weight management (23:58) Bone health, vitamin D, DEXA scans, and early aging (29:32) Sexual health and hormonal changes (32:43) Everyday living after transplant (36:07) Psychological and cognitive hurdles in survivorship (38:16) Pulmonary function tests and liver monitoring (40:42) Closing thoughts National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/Check out our valued nbmtLINK resource books, some for sale, some free as downloadable, https://www.nbmtlink.org/shop/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.This content is provided for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. It is crucial to consult directly with a qualified healthcare professional regarding any medical conditions, treatment options, or other health concerns.The views and opinions expressed by the speakers are their own and do not necessarily reflect the official policy or position of the nbmtLINK. Unless otherwise stated in an official policy, the nbmtLINK does not endorse any specific treatments, products, or services mentioned by the speakers. Reliance on any information provided is solely at your own risk.The Marrow Masters Podcast is produced by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Season 20 of the Marrow Masters Podcast, produced by the National Bone Marrow Transplant LINK, focuses on thriving in survivorship post-transplant. You'll hear from patients, caregivers, doctors and social workers as they share their best tips and practices. Season 20 of the Marrow Masters Podcast is sponsored by Incyte and Sanofi. Look for Season 20 on May 27, 2026. And be sure not to miss an episode! Follow our show for free on Apple, Spotify, YouTube, or wherever you're listening right now. National Bone Marrow Transplant Link - (800) LINK-BMT, or (800) 546-5268.nbmtLINK Website: https://www.nbmtlink.org/Check out our valued nbmtLINK resource books, some for sale, some free as downloadable, https://www.nbmtlink.org/shop/nbmtLINK Facebook Page: https://www.facebook.com/nbmtLINKFollow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/The nbmtLINK YouTube Page can be found by clicking here.This content is provided for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. It is crucial to consult directly with a qualified healthcare professional regarding any medical conditions, treatment options, or other health concerns.The views and opinions expressed by the speakers are their own and do not necessarily reflect the official policy or position of the nbmtLINK. Unless otherwise stated in an official policy, the nbmtLINK does not endorse any specific treatments, products, or services mentioned by the speakers. Reliance on any information provided is solely at your own risk.The Marrow Masters Podcast is produced by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, we are joined by Jeff Hooke, former investment banking, private equity, and private debt executive turned academic critic of alternative investments, for a rigorous and provocative examination of private equity, private credit, and institutional investing. Jeff draws on decades of experience in finance and years of academic research to challenge many of the assumptions driving institutional and retail allocations to private markets. We discuss why pension plans and endowments continue pouring capital into alternatives despite evidence of underperformance, how private market valuations can obscure true risk, and why the fee structures embedded in private funds create enormous hurdles for investors. Jeff explains the methodological challenges of benchmarking private investments, the role of investment consultants and industry incentives, and why illiquidity and opaque reporting make private assets especially difficult for retail investors to evaluate. Along the way, we explore survivorship bias, public market equivalents, unrealized valuations, and the growing push to bring private assets into retirement portfolios. This conversation is an in-depth look at the incentives, risks, and realities shaping the modern alternatives industry.   Key Points From This Episode: (0:00:18) Introduction to Jeff Hooke and the focus on private equity, private credit, and alternative investments. (0:04:21) Why institutions and retail investors continue allocating heavily to alternatives. (0:04:33) What institutional investors are and how pension plans and endowments operate. (0:05:52) Why institutional staff may prefer complexity over simple index investing. (0:07:55) How early private equity outperformance fueled lasting enthusiasm for alternatives. (0:08:47) Why trustees often rely heavily on staff and consultants for investment decisions. (0:09:29) The social and psychological appeal of "exotic" investments. (0:10:28) Why institutional investors often resist criticism of private markets. (0:11:56) The CalPERS example: underperforming a simple 60/40 index despite complexity. (0:13:28) The role investment consultants play as institutional "gatekeepers." (0:15:42) Why many pension plans and endowments may have underperformed due to alternatives. (0:17:26) Findings from The Grand Experiment and research on private equity fund performance. (0:18:30) Why institutions struggled to replicate Yale's endowment success under David Swensen. (0:20:57) Gross versus net performance in private equity—and the impact of fees. (0:21:30) The extreme dispersion between top- and bottom-performing private equity funds. (0:23:26) The weak persistence of private equity manager outperformance. (0:25:27) Why private investments expanded rapidly after the Global Financial Crisis. (0:25:54) The illusion of smoother returns in private markets due to subjective valuations. (0:28:13) Why benchmarking private equity performance is methodologically difficult. (0:31:13) How private market data can support conflicting performance narratives. (0:33:41) Why public market equivalent (PME) is one of the best benchmarking approaches. (0:36:59) Survivorship bias and non-reporting funds in private market databases. (0:40:09) The rise of private credit and its role in financing leveraged buyouts. (0:42:29) Findings from Jeff's private credit research: no evidence of outperformance versus public ETFs. (0:45:15) Jeff's response to Cliffwater's critique of his private credit paper. (0:47:15) Why retail investors may underestimate the risks and costs of private alternatives. (0:49:14) Conflicts of interest and fee incentives in wealth management distribution. (0:51:03) The impact of unrealized valuations and unsold holdings on reported returns. (0:53:15) Why many private equity funds still hold large unrealized positions after a decade. (0:56:05) Whether private equity ownership actually improves company operations. (0:57:42) The major liquidity risks facing retail investors in private funds. (0:59:20) Canadian private real estate funds, gating, and redemption problems. (1:02:01) Comparing private market fees to ultra-low-cost public index funds. (1:06:46) The long-term impact of bringing private assets into retail retirement accounts. (1:08:17) How much "play money" investors should allocate to speculative alternatives. (1:10:49) Why leverage layered on top of private funds creates additional risk.   Links From Today's Episode: Meet with PWL Capital: https://calendly.com/d/3vm-t2j-h3p Rational Reminder on iTunes — https://itunes.apple.com/ca/podcast/the-rational-reminder-podcast/id1426530582. Rational Reminder on Instagram — https://www.instagram.com/rationalreminder/ Rational Reminder on YouTube — https://www.youtube.com/channel/ Benjamin Felix — https://pwlcapital.com/our-team/ Benjamin on X — https://x.com/benjaminwfelix Benjamin on LinkedIn — https://www.linkedin.com/in/benjaminwfelix/ Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com)

As total ankle arthroplasty (TAA) use evolves, understanding implant longevity and survivorship expectations has become critical for patient counseling and decision making. The purpose of this study was to determine the long-term survivorship of the INBONE II TAA. In Conclusion, ten-year survivorship of INBONE II TAA was 93% in this cohort. Despite periprosthetic osteolysis and/or peri-implant lucency, the reoperation rate was low. Although the small number of failures prevented statistically significant conclusions, radiographic patterns suggest possible higher risk of failure in those with greater varus deformity. Click here to read the article.

Dave Schlueter of the Law Offices of David R. Schlueter joins Jon Hansen to explain joint tenancy with right of survivorship and what you should know about it. To learn more about what Dave Schlueter can help you with, go to schlueterlawoffice.com or call 1-630-285-5300.

In this episode, we are joined by Elroy Dimson, Professor of Finance at Cambridge Judge Business School and co-creator of the Dimson-Marsh-Staunton (DMS) dataset, for a sweeping and deeply insightful conversation on financial history, market behavior, and the evolution of global investing. Elroy walks us through the origins of the groundbreaking Triumph of the Optimists, the challenges of assembling over 100 years of global return data, and the critical biases that once shaped our understanding of markets. We explore how expanding beyond U.S.-centric data reshaped expectations for the equity risk premium, why economic growth doesn't necessarily translate into higher stock returns, and what history reveals about diversification, factor investing, and investor behavior. Elroy also shares lessons from his work with major institutions like Norway's sovereign wealth fund, discusses the surprising long-term outperformance of railways, and offers a grounded perspective on future expected returns. This episode is a masterclass in using history to inform better financial decisions. Key Points From This Episode: (0:04:00) Introduction to Elroy Dimson and the significance of the DMS dataset. (0:05:07) Why understanding financial history is essential for thinking about the future. (0:05:24) The origin story of Triumph of the Optimists and assembling global return data. (0:09:06) How long-term datasets are built from academic and commercial sources. (0:11:33) Survivorship bias in historical indices and why it matters. (0:13:35) "Easy data bias" and how it leads to overstated historical returns. (0:15:32) Accounting for failed markets and geopolitical disruptions in global data. (0:18:33) How global data changed expectations for the equity risk premium. (0:21:09) Why 20th-century equity returns were a "pleasant surprise." (0:22:17) U.S. market dominance and the challenge of extrapolating its success. (0:24:11) Market composition in 1900 and the dominance of railway stocks. (0:25:52) Why railways outperformed despite shrinking market share. (0:29:03) The surprising disconnect between economic growth and stock returns. (0:31:28) Why investing in recovering markets requires extreme patience and conviction. (0:33:32) Value investing: historical success and recent struggles. (0:35:00) Why economic growth benefits many—but not necessarily stock investors. (0:35:59) The long-term benefits of global diversification. (0:40:01) Why diversification reduces risk—but doesn't create returns for everyone. (0:42:29) Explaining persistent home country bias among investors. (0:47:46) Industry diversification becoming more important over time. (0:49:50) The rise and evolution of size, value, and momentum factors. (0:54:17) Why factor premiums should be monitored—not blindly followed. (0:57:27) The equity risk premium: why it's crucial—and uncertain. (1:00:15) A realistic estimate: ~3% equity risk premium going forward. (1:02:33) Translating that into ~5% real expected equity returns. (1:05:10) Staying optimistic: invest long-term and live modestly. (1:05:58) The risk of pessimism: losing purchasing power in safe assets. (1:08:06) The evolving role of bonds as diversifiers. (1:09:55) Why market timing is a losing strategy. (1:11:00) Elroy's definition of success: happy children and grandchildren. Links From Today's Episode: Meet with PWL Capital: https://calendly.com/d/3vm-t2j-h3p Rational Reminder on iTunes — https://itunes.apple.com/ca/podcast/the-rational-reminder-podcast/id1426530582. Rational Reminder on Instagram — https://www.instagram.com/rationalreminder/ Rational Reminder on YouTube — https://www.youtube.com/channel/ Benjamin Felix — https://pwlcapital.com/our-team/ Benjamin on X — https://x.com/benjaminwfelix Benjamin on LinkedIn — https://www.linkedin.com/in/benjaminwfelix/ Benjamin Warwick on LinkedIn - https://www.linkedin.com/in/braden-warwick-a40b48a3 Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com)

Send us Fan MailTrusts, Estates & Joint Accounts | Series 65 and Series 66 Exam PrepEverything you need on trusts, estates, and joint accounts for the Series 65 (Uniform Investment Adviser Law Examination) and Series 66 (Uniform Combined State Law Examination). This topic isn't a huge percentage of the exam, but it's easy points if you know the patterns NASAA likes to test.What this video covers:Joint account types — JTWROS (Joint Tenants with Rights of Survivorship), Tenants in Common, Tenants by the Entirety, and community property. The survivor question and how the exam tests it.The three players in every trust — grantor (settlor, trustor), trustee, and beneficiary.Revocable vs irrevocable trusts — what changes, who pays the taxes, why the IRS doesn't care about your revocable trust, and what you actually get in return for giving up control.Testamentary trusts — when they're funded and why probate still applies.Why people set up trusts in the first place — probate avoidance, privacy, control after death, and estate tax reduction. The four real reasons, ranked.The Prudent Investor Rule under the Uniform Prudent Investor Act — fiduciary duty, total portfolio approach, diversification, and the wrong answers the exam loves to throw at you.Trustee duties with multiple beneficiaries — balancing income beneficiaries against remainder beneficiaries, what the trustee considers, and what the trustee absolutely does not care about.Estate accounts — executor vs administrator, Letters Testamentary vs Letters of Administration, and how the account actually works.Common Series 65 and 66 exam questions answered:Who gets taxed on a revocable trust? The grantor. Who gets taxed on an irrevocable trust? The trust or the beneficiary. Does a revocable trust reduce estate taxes? No. Does a revocable trust avoid probate? Yes. When is a testamentary trust funded? At the grantor's death. Who can trade a trust account? The trustee. What standard does a trustee follow? Prudent investor rule.Taught by Ken Boyd — former NYSE floor trader (1989–2009) and founder of Capital Advantage Tutoring. 35 years on Wall Street. Series 7, SIE, Series 63, 65, and 66 exam prep.

Some founders build solid companies.A few build something far bigger than what looked reasonable at the time.What explains that gap?In this episode of the Prime Venture Partners Podcast, Amit Somani, Managing Partner at Prime Venture Partners, speaks with Dr. Julie Gurner, Executive Performance Coach on the psychology behind exceptional founders.They get into the self belief, audacity, resilience, and invisible rules that shape how far people go.The conversation also explores:• What “maniacal focus” looks like in standout founders• The imaginary rules that limit what founders build, earn, and pursue• Why tying your identity to your company can lead to worse decisions• Why playing to your strengths creates more leverage than trying to do it all• What AI can and cannot do for leaders and foundersIf you are building something and want to understand the mental side of exceptional performance, this episode is worth your time.

In this episode of Onc Now, Claire Snyder explores the growing importance of patient-reported outcomes and quality of life in modern oncology care. She discusses the challenges and opportunities of integrating patient perspectives into routine practice, as well as the global effort to standardise these measures through initiatives such as the PROTEUS Consortium. The conversation also highlights the evolving needs of survivors of cancer, key priorities in survivorship care, and what the future holds for patient-centred oncology.  Timestamps:   00:00 – Introduction   01:41 – Modern oncology care  03:56 – Patient-reported outcomes (PRO) interest origin   05:10 - PRO implementation challenges   06:36 - PROTEUS Consortium mission   08:33 - Survivorship care priorities   09:45 - Childhood survivor insights   12:35 - Advice for newcomers   13:37 - Future quality of life developments   14:41 - Three wishes 

Episode Description In this episode of The MADLOVE Your Life Show, Mary Dee is joined by Pat Berry and Michael Hamburger for a powerful and deeply personal conversation about their shared experience being cancer survivors. Each of them has faced a different type of cancer and a different journey through diagnosis, treatment, and recovery. Together, they open up about how they discovered something was wrong, the decisions they had to make under pressure, and what it truly means to navigate life during and after cancer. From fast-moving medical choices to emotional and mental challenges, this conversation sheds light on the realities of survivorship while offering hope, perspective, and strength for anyone facing a health scare. This episode is both honest and inspiring, showing that while the journey may look different for everyone, there is always a path forward. You'll hear: • The early signs that led to each diagnosis. • How major treatment decisions were made under uncertainty. • The emotional and mental challenges during the process. • Why mindset plays a critical role in healing and recovery. • The importance of early detection and listening to your body. • How cancer impacts identity, business, and daily life. • Different approaches to treatment and personal choice. • What survivorship really looks like at different stages. • Lessons on gratitude, presence, and what truly matters. If this episode speaks to you… If you or someone you love is navigating a health challenge, or if you've ever faced uncertainty in life, this episode offers perspective, encouragement, and real-life insight. Because sometimes, life's biggest challenges can bring the clearest understanding of what truly matters.

Total ankle arthroplasty (TAA) is increasingly used as a motion-preserving alternative to ankle arthrodesis for end-stage ankle disease. The Salto Talaris fixed-bearing prosthesis was designed to enhance joint kinematics while minimizing bone resection and reducing complications seen in earlier implant generations. This study reports midterm clinical outcomes, including survivorship, complications, reoperation and failure rates in a large, single-surgeon cohort. In conclusion, in this large cohort, the Salto Talaris TAA was associated with improvements in patient-reported quality of life, activity, and pain, and showed high survivorship with relatively low failure (5.4%) and reoperation (12.0%) rates at an average of 5.5 years after index surgery.   Click here to read the article.

In this episode of Onc Now, Patricia Ganz sits down with EMJ to explore the evolving field of cancer survivorship. From managing long-term treatment effects to improving transitions into post-treatment care, she highlights key gaps in research, the growing role of patient-reported outcomes, and the importance of integrating policy, advocacy, and clinical practice to better support survivors.  Timestamps: 00:00 – Introduction   01:24 - Career survivorship inspiration  03:10 - Survivorship field evolution   04:10 - Late effects challenges   06:40 - Post-treatment care transition   07:58 - Patient-reported outcomes impact   10:14 - Advocacy policy research intersection   13:29 - Advice for new researchers   15:07 – Bench to beside challenges  17:40 – Equipping younger clinicians   19:16 - Future survivorship innovations   20:14 - Three survivorship wishes  

This episode features a conversation with Murali Shanmugavelan and Sareeta Amrute about how caste structures IT workspaces and communication infrastructures. We began with their reflections on how they came to scholarship and advocacy on caste. The rest of our discussion covered a range of topics including, the ideology of tech as immaterial and disembodied, the role of tech within racial and caste supremacist projects, how and why large language models systematically favor dominant caste norms, the internal and external pressures required for tech companies to advance social equity, the necessity and limits of law in advancing protections against caste hate speech and other forms of identity-based violence and discrimination, and the need to balance visibility and secrecy as two dimensions of the anticaste struggle. Guest bios: Murali Shanmugavelan: Affiliate with the Data & Society Research Institute and Senior Fellow at the School of Oriental and African Studies. Sareeta Amrute: Associate Professor of Strategic Design at Parsons School of Design, Affiliate Faculty of Anthropology at the New School, and Principal Researcher at the Data & Society Research Institute. References: Karve: Dhondo Keshav Karve set up a home and school for widows in the city of Pune in Maharashtra in 1896. The institution, which is now called Maharshi Karve Stree Shikshan Samstha, runs 60 sites for women's education. Periyar: E.V. Ramasamy Naicker, commonly known as Periyar, was a writer, social revolutionary, and politician who was one of the principal ideologues of the Self-Respect Movement. Western Ghats: a mountain range that stretches along the western coast of the Indian peninsula. Sriram Krishnan: tech executive and Senior White House Policy Advisor on Artificial Intelligence in the second Trump administration. Bruno Latour: French philosopher known for his work in the field of Science and Technology Studies. Maha Shivarathri: annual festival to celebrate the deity, Shiva. Mimi Onuoha: Nigerian American visual artist and academic whose work examines the effect of data collection and technology on society. Thenmozhi Soundararajan: founder of the Dalit feminist organization Equality Labs and author The Trauma of Caste: A Dalit Feminist Meditation on Survivorship, Healing, and Abolition. The Hindu Code Bills aimed to codify and modernize Hindu personal laws, promoting gender equality in marriage, inheritance, and adoption. Gail Omvedt: sociologist and anticaste activist whose work on Dalit epistemology and politics was path-defining. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

This episode features a conversation with Murali Shanmugavelan and Sareeta Amrute about how caste structures IT workspaces and communication infrastructures. We began with their reflections on how they came to scholarship and advocacy on caste. The rest of our discussion covered a range of topics including, the ideology of tech as immaterial and disembodied, the role of tech within racial and caste supremacist projects, how and why large language models systematically favor dominant caste norms, the internal and external pressures required for tech companies to advance social equity, the necessity and limits of law in advancing protections against caste hate speech and other forms of identity-based violence and discrimination, and the need to balance visibility and secrecy as two dimensions of the anticaste struggle. Guest bios: Murali Shanmugavelan: Affiliate with the Data & Society Research Institute and Senior Fellow at the School of Oriental and African Studies. Sareeta Amrute: Associate Professor of Strategic Design at Parsons School of Design, Affiliate Faculty of Anthropology at the New School, and Principal Researcher at the Data & Society Research Institute. References: Karve: Dhondo Keshav Karve set up a home and school for widows in the city of Pune in Maharashtra in 1896. The institution, which is now called Maharshi Karve Stree Shikshan Samstha, runs 60 sites for women's education. Periyar: E.V. Ramasamy Naicker, commonly known as Periyar, was a writer, social revolutionary, and politician who was one of the principal ideologues of the Self-Respect Movement. Western Ghats: a mountain range that stretches along the western coast of the Indian peninsula. Sriram Krishnan: tech executive and Senior White House Policy Advisor on Artificial Intelligence in the second Trump administration. Bruno Latour: French philosopher known for his work in the field of Science and Technology Studies. Maha Shivarathri: annual festival to celebrate the deity, Shiva. Mimi Onuoha: Nigerian American visual artist and academic whose work examines the effect of data collection and technology on society. Thenmozhi Soundararajan: founder of the Dalit feminist organization Equality Labs and author The Trauma of Caste: A Dalit Feminist Meditation on Survivorship, Healing, and Abolition. The Hindu Code Bills aimed to codify and modernize Hindu personal laws, promoting gender equality in marriage, inheritance, and adoption. Gail Omvedt: sociologist and anticaste activist whose work on Dalit epistemology and politics was path-defining. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/anthropology

This episode features a conversation with Murali Shanmugavelan and Sareeta Amrute about how caste structures IT workspaces and communication infrastructures. We began with their reflections on how they came to scholarship and advocacy on caste. The rest of our discussion covered a range of topics including, the ideology of tech as immaterial and disembodied, the role of tech within racial and caste supremacist projects, how and why large language models systematically favor dominant caste norms, the internal and external pressures required for tech companies to advance social equity, the necessity and limits of law in advancing protections against caste hate speech and other forms of identity-based violence and discrimination, and the need to balance visibility and secrecy as two dimensions of the anticaste struggle. Guest bios: Murali Shanmugavelan: Affiliate with the Data & Society Research Institute and Senior Fellow at the School of Oriental and African Studies. Sareeta Amrute: Associate Professor of Strategic Design at Parsons School of Design, Affiliate Faculty of Anthropology at the New School, and Principal Researcher at the Data & Society Research Institute. References: Karve: Dhondo Keshav Karve set up a home and school for widows in the city of Pune in Maharashtra in 1896. The institution, which is now called Maharshi Karve Stree Shikshan Samstha, runs 60 sites for women's education. Periyar: E.V. Ramasamy Naicker, commonly known as Periyar, was a writer, social revolutionary, and politician who was one of the principal ideologues of the Self-Respect Movement. Western Ghats: a mountain range that stretches along the western coast of the Indian peninsula. Sriram Krishnan: tech executive and Senior White House Policy Advisor on Artificial Intelligence in the second Trump administration. Bruno Latour: French philosopher known for his work in the field of Science and Technology Studies. Maha Shivarathri: annual festival to celebrate the deity, Shiva. Mimi Onuoha: Nigerian American visual artist and academic whose work examines the effect of data collection and technology on society. Thenmozhi Soundararajan: founder of the Dalit feminist organization Equality Labs and author The Trauma of Caste: A Dalit Feminist Meditation on Survivorship, Healing, and Abolition. The Hindu Code Bills aimed to codify and modernize Hindu personal laws, promoting gender equality in marriage, inheritance, and adoption. Gail Omvedt: sociologist and anticaste activist whose work on Dalit epistemology and politics was path-defining. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/sociology

This episode features a conversation with Murali Shanmugavelan and Sareeta Amrute about how caste structures IT workspaces and communication infrastructures. We began with their reflections on how they came to scholarship and advocacy on caste. The rest of our discussion covered a range of topics including, the ideology of tech as immaterial and disembodied, the role of tech within racial and caste supremacist projects, how and why large language models systematically favor dominant caste norms, the internal and external pressures required for tech companies to advance social equity, the necessity and limits of law in advancing protections against caste hate speech and other forms of identity-based violence and discrimination, and the need to balance visibility and secrecy as two dimensions of the anticaste struggle. Guest bios: Murali Shanmugavelan: Affiliate with the Data & Society Research Institute and Senior Fellow at the School of Oriental and African Studies. Sareeta Amrute: Associate Professor of Strategic Design at Parsons School of Design, Affiliate Faculty of Anthropology at the New School, and Principal Researcher at the Data & Society Research Institute. References: Karve: Dhondo Keshav Karve set up a home and school for widows in the city of Pune in Maharashtra in 1896. The institution, which is now called Maharshi Karve Stree Shikshan Samstha, runs 60 sites for women's education. Periyar: E.V. Ramasamy Naicker, commonly known as Periyar, was a writer, social revolutionary, and politician who was one of the principal ideologues of the Self-Respect Movement. Western Ghats: a mountain range that stretches along the western coast of the Indian peninsula. Sriram Krishnan: tech executive and Senior White House Policy Advisor on Artificial Intelligence in the second Trump administration. Bruno Latour: French philosopher known for his work in the field of Science and Technology Studies. Maha Shivarathri: annual festival to celebrate the deity, Shiva. Mimi Onuoha: Nigerian American visual artist and academic whose work examines the effect of data collection and technology on society. Thenmozhi Soundararajan: founder of the Dalit feminist organization Equality Labs and author The Trauma of Caste: A Dalit Feminist Meditation on Survivorship, Healing, and Abolition. The Hindu Code Bills aimed to codify and modernize Hindu personal laws, promoting gender equality in marriage, inheritance, and adoption. Gail Omvedt: sociologist and anticaste activist whose work on Dalit epistemology and politics was path-defining. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/south-asian-studies

This episode features a conversation with Murali Shanmugavelan and Sareeta Amrute about how caste structures IT workspaces and communication infrastructures. We began with their reflections on how they came to scholarship and advocacy on caste. The rest of our discussion covered a range of topics including, the ideology of tech as immaterial and disembodied, the role of tech within racial and caste supremacist projects, how and why large language models systematically favor dominant caste norms, the internal and external pressures required for tech companies to advance social equity, the necessity and limits of law in advancing protections against caste hate speech and other forms of identity-based violence and discrimination, and the need to balance visibility and secrecy as two dimensions of the anticaste struggle. Guest bios: Murali Shanmugavelan: Affiliate with the Data & Society Research Institute and Senior Fellow at the School of Oriental and African Studies. Sareeta Amrute: Associate Professor of Strategic Design at Parsons School of Design, Affiliate Faculty of Anthropology at the New School, and Principal Researcher at the Data & Society Research Institute. References: Karve: Dhondo Keshav Karve set up a home and school for widows in the city of Pune in Maharashtra in 1896. The institution, which is now called Maharshi Karve Stree Shikshan Samstha, runs 60 sites for women's education. Periyar: E.V. Ramasamy Naicker, commonly known as Periyar, was a writer, social revolutionary, and politician who was one of the principal ideologues of the Self-Respect Movement. Western Ghats: a mountain range that stretches along the western coast of the Indian peninsula. Sriram Krishnan: tech executive and Senior White House Policy Advisor on Artificial Intelligence in the second Trump administration. Bruno Latour: French philosopher known for his work in the field of Science and Technology Studies. Maha Shivarathri: annual festival to celebrate the deity, Shiva. Mimi Onuoha: Nigerian American visual artist and academic whose work examines the effect of data collection and technology on society. Thenmozhi Soundararajan: founder of the Dalit feminist organization Equality Labs and author The Trauma of Caste: A Dalit Feminist Meditation on Survivorship, Healing, and Abolition. The Hindu Code Bills aimed to codify and modernize Hindu personal laws, promoting gender equality in marriage, inheritance, and adoption. Gail Omvedt: sociologist and anticaste activist whose work on Dalit epistemology and politics was path-defining. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science-technology-and-society

This episode of Excess Returns Weekly Recap breaks down one of the most complex market environments in recent memory, from the global oil shock and its economic ripple effects to base rates, AI-driven productivity, and private credit risks. Jack Forehand and Matt Zeigler synthesize insights from Bob Elliott, Chris Mayer, Robert, and Larry Swedroe to help investors understand what matters, what's being mispriced, and where conviction should (and shouldn't) exist.Topics covered:How oil supply shocks translate into inflation and reduced consumer spendingWhy oil demand is inelastic and creates mechanical economic slowdownsThe difference between consumer surplus and true productivity gains from AIWhy better tools don't necessarily translate into higher earningsUnderstanding base rates and when it makes sense to bet against themHow extreme outliers drive market returns and portfolio constructionSurvivorship bias vs studying exceptional businesses the right wayPrivate credit risks, liquidity mechanisms, and media-driven narrativesWhy redemption fears in private credit may be overstatedThe importance of intellectual humility in macro investingWhy investors often have no edge in geopolitical forecastingIdentifying cross-asset mispricings instead of predicting outcomesHow AI may increase competition but not necessarily create more winnersThe persistence of winner-take-all dynamics across technological shiftsHow to think about conviction, uncertainty, and portfolio positioning in volatile environmentsTimestamps:00:00 Oil shock impact on consumer spending and inflation mechanics00:01:06 Why this market environment is unusually confusing for investors00:02:22 How oil supply shocks translate into price spikes and inflation00:05:20 The real-world impact of higher energy costs on household spending00:10:00 Base rates vs extreme outcomes in investing00:11:39 Survivorship bias and what investors misunderstand about outliers00:18:03 Private credit redemption risks and liquidity dynamics explained00:23:00 Media narratives vs actual cash flows in private credit funds00:27:11 AI productivity vs consumer surplus and why it matters00:30:26 Why better tools don't always lead to higher earnings00:33:37 How to use base rates alongside conviction in investing decisions00:38:58 Why investors have no edge in predicting geopolitical outcomes00:41:00 Cross-asset signals and what markets may be mispricing00:45:12 How AI could reshape competition but not change winner dynamics00:47:57 When base rates break and how technological shifts reset expectations

In Part 2 of Jamie Vaughn's conversation with intimacy educator and cancer survivor Claire Rumore, the discussion turns to a topic rarely addressed in cancer care: intimacy and sexuality after cancer.Jamie and Claire explore how cancer treatments, menopause, body changes, and emotional healing can impact libido, relationships, and self-confidence. Claire shares powerful insights on redefining intimacy, navigating mismatched desire, and helping survivors reconnect with their bodies and partners after cancer.This episode offers compassionate guidance for patients, survivors, and partners navigating life and relationships after cancer.Resourceshttps://clairerumore.comhttps://cancerandintimacy.comUse code CAI20 for 20% off resources in Claire's store.InstagramSubstackLinkedIn Newsletter

The Journal of Arthroplasty: The Cut brings you another very special episode based on Knee Society Proceedings that highlight important research about knee arthroplasty. In this episode of The Cut, our hosts Kim K. Tucker, MD and Nathanael D. Heckmann, MD welcomed guests Neil P. Sheth, MD, FACS and Rafael J. Sierra, MD to discuss all things on hip replacements in patients that are early in adulthood (30 or less). Our hosts begin the podcast discussing Dr. Sheth’s study that included patients less than 21- years old, but with a median age of 16 who underwent full hip replacement surgery. What results looked like after a five year follow up – favorable or not, how he determines to perform a full hip replacement versus hip preservation and how does a full hip replacement in young patients compare to those done with older adults? While Dr. Sheth's study showed that modern THA can succeed in teens, Dr. Sierra study focused on how those results transition into early adulthood when activity demands increase. Dr. Sierra's study included patients less than 30 – years old (median age of 23) with a seven-year follow-up. Survivorship in this study shocked even Dr. Sierra. Our guests also discuss how they approach the conversation of a total hip replacement with parents – what shared decision-making looks like, how they acquire consent from them and how they rely on them to monitor activity levels with the child. I think you’ll find this podcast extremely helpful, especially if you’ve encountered a younger patient with hip complications. Enjoy and thanks for listening to The Journal of Arthroplasty: The Cut! In This Episode: Nathanael D. Heckmann, MD Neil P. Sheth, MD, FACS Rafael J. Sierra, MD Kim K. Tucker, MD The post Total Hip Arthroplasty in Young Patients first appeared on AAHKS.

The Journal of Arthroplasty: The Cut brings you another very special episode based on Knee Society Proceedings that highlight important research about knee arthroplasty. In this episode of The Cut, our hosts Kimberly K. Tucker, MD and Nathanael D. Heckmann, MD welcomed guests Neil P. Sheth, MD, FACS and Rafael J. Sierra, MD to discuss all things on hip replacements in patients that are early in adulthood (30 or less). Our hosts begin the podcast discussing Dr. Sheth’s study that included patients less than 21- years old, but with a median age of 16 who underwent full hip replacement surgery. What results looked like after a five year follow up – favorable or not, how he determines to perform a full hip replacement versus hip preservation and how does a full hip replacement in young patients compare to those done with older adults? While Dr. Sheth's study showed that modern THA can succeed in teens, Dr. Sierra study focused on how those results transition into early adulthood when activity demands increase. Dr. Sierra's study included patients less than 30 – years old (median age of 23) with a seven-year follow-up. Survivorship in this study shocked even Dr. Sierra.  Our guests also discuss how they approach the conversation of a total hip replacement with parents – what shared decision-making looks like, how they acquire consent from them and how they rely on them to monitor activity levels with the child. I think you’ll find this podcast extremely helpful, especially if you’ve encountered a younger patient with hip complications. Enjoy and thanks for listening to The Journal of Arthroplasty: The Cut! In This Episode: Nathanael D. Heckmann, MD Neil P. Sheth, MD, FACS Rafael J. Sierra, MD Kimberly K. Tucker, MD The post Total Hip Arthroplasty in Young Patients first appeared on AAHKS.

"The disease is increasingly managed as a chronic condition rather than a diagnosis with an immediate terminal outcome. Particularly, with earlier and more effective and sustained treatment options, we can make this disease a very chronic, long-term, livable condition. I want to make sure that patients are aware that this is not a death sentence. This is something that patients can live with for the long term," Ann McNeill, RN, MSN, APN, nurse practitioner at the John Theurer Cancer Center at Jersey Shore University Medical Center in Neptune, NJ, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about long-term multiple myeloma considerations for oncology nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by March 6, 2027. Ann McNeill is on the speakers' bureau for Pfizer. This financial relationship has been mitigated. All other planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to management of long-term side effects related to multiple myeloma and treatment. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 401: Multiple Myeloma Treatment Considerations for Oncology Nurses Episode 398: An Overview of Multiple Myeloma for Oncology Nurses Episode 339: A Lesson on Labs: How to Monitor and Educate Patients With Cancer Episode 201: Which Survivorship Care Model Is Right for Your Patient? ONS Voice articles: Effective Care Transitions Are Essential for New Multiple Myeloma Treatments Infection Prevention for Oncology Nurses Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations Nurse-Led Survivorship Programs Sexual Considerations for Patients With Cancer Oncology Nursing Forum articles:  A Qualitative Study of the Experiences of Living With Multiple Myeloma Changes in Health-Related Quality of Life During Multiple Myeloma Treatment: A Qualitative Interview Study ONS book: Multiple Myeloma: A Textbook for Nurses (third edition) ONS Huddle Cards: Pain Management Sexuality Survivorship Care Plan ONS Learning Libraries: Hematology, Cellular Therapy, and Stem Cell Transplantation Survivorship ONS Symptom Intervention resources: Chronic Pain Fatigue Peripheral Neuropathy American Cancer Society: Living as a Multiple Myeloma Survivor Blood Cancer United: Resources for Healthcare Professionals International Myeloma Foundation: Resources and Support for the Myeloma Community Multiple Myeloma Research Foundation: Empower Patients and the Community To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We do consider myeloma an incurable hematologic malignancy, even though we have had improvements in survival. But just like for any malignancy, our goal is to maximize survival. We want to eliminate as many myeloma cells as we possibly can. And subsequently, we want to improve the quality of life for these patients in the long term. So those are basically our treatment goals. That's what we think of when we're treating patients all throughout their treatment journey." TS 1:39 "It is very typical for patients along their journey to have received several lines of therapy. I think it's important to realize that the cells acquire new mutations, making them more resistant to these further subsequent lines of therapy. We see quicker, more aggressive relapses in those patients with multiple prior lines of therapy. We can see an increase in the CRAB symptoms, which are the calcium elevations, the renal dysfunction, profound anemia, and even bone disease. We can see a rapid rise in the monoclonal protein in the labs or even a very rapid rise in the involved light chain in that serum free light chain assay, so it's important to monitor these labs." TS 9:14 "All oncology nurses are focusing on these survivorship plans now. And I think that's a great thing when you think about a diagnosis of cancer and a survivorship plan, because it means these patients are living a longer time. We still look at long-term health maintenance guidelines depending on the patient's sex and their age. ... I think preventing infection is always going to be something absolutely on the forefront in our survivorship plan with myeloma. I mean, myeloma is an immune system malignancy. The treatments that we have given patients can sometimes, especially in later life therapies, further compromise the immune system. So, we're always looking to prevent serious infection." TS 12:46 "Patients get treatment, especially induction therapy. They may or may not get transplant. They may have been on a very minor maintenance schedule, depending on their age. And they feel really well. And then they decide not to return for their follow-up because they feel so good. I think nurses are critical in the communication aspect of the patient-provider aspect. So, nurses are really the key means of communication. The providers are absolutely important—the physicians, the nurse practitioners and every other member of the team—but I think the nurses have a really special rapport with patients. They're usually the ones providing the education on the treatment regimens. They're managing the toxicity profiles. They're doing all the coordination of care between visits. They are really going to be the ones telling the patient, 'Hey, you're going to feel good and that's a wonderful thing, but you still need to come once a month or once every six weeks or once every two months for your labs.'" TS 15:17  "It has been amazing. The science, the research, the treatments, the approvals from the U.S. Food and Drug Administration. Survivorship has improved dramatically. Let's take the first few years of the new century, right? The five-year survival rate was about 38%. If you then jump to 2015–2019, which is still seven plus years ago, it has doubled. So, we're talking about anywhere from 60%–80% over a five-year survival. So that's an amazing improvement in their five-year survival rate for myeloma." TS 23:28 "Survivorship in myeloma begins at diagnosis, not just after treatment. And I think that because it is managed as a chronic, often relapsing disease, it does require lifelong evolving care. Patients should realize that they will know us for the rest of their lives. We will know everything about you. I always tell them, 'I will know everything about your hobbies, your children, your grandchildren, what you love to do on the weekends.' It's very important that that point is made right at diagnosis, not just after so many lines of treatment. It's very important that we are going to follow these patients throughout their journey." TS 28:18

This podcast often explores ambition, leadership, confidence, and impact. But sometimes? Woman's work looks a whole lot more like survival. Not the inspirational quote version. Not the neat-and-tidy comeback story. Not the “and then she rose” highlight reel. This episode of This Is Woman's Work dives into the raw, relentless, day-by-day kind of survival — the kind that asks someone to keep showing up while life is actively coming apart. Nicole Kalil is joined by Kathy Giusti — two-time cancer survivor, healthcare entrepreneur, founder of the Multiple Myeloma Research Foundation (MMRF), and author of Fatal to Fearless. After being diagnosed with multiple myeloma at 37 and given three years to live, Kathy turned her prognosis into a movement that helped transform cancer research and dramatically extend life expectancy for patients. Yes. From terminal diagnosis to systemic change. In This Episode, They Discuss: What survival really looks like after a terminal cancer diagnosis Why resilience isn't pretty — and rarely feels brave in the moment The difference between “fighting” cancer and running a marathon with it How to advocate for yourself inside a broken healthcare system Why women must step into the role of CEO of their own healthcare The power (and responsibility) of using social media wisely for medical information The hard truth about boundaries, burnout, and forgetting to live while trying to stay alive Kathy shares what it meant to raise a family while preparing for death. To build a global research foundation while undergoing chemotherapy. To carry hope, fear, responsibility, and grief — all at once. And perhaps most powerfully, she shares the regret she didn't anticipate: that in trying to save her life (and so many others), she sometimes forgot to fully live it. Thank you to our sponsors! Shopify has everything all in one place, making your life easier and your business operations smoother. Sign up for your one-dollar-per-month trial today at shopify.com/tiww  Connect with Kathy: Website: https://www.kathygiusti.com/ Book: https://www.kathygiusti.com/book  LI: https://www.linkedin.com/in/kathygiusti/ IG: https://www.instagram.com/kathy.giusti/ FB: https://www.facebook.com/KathyGiustiMMRF Related Podcast Episodes: 161 / Survivorship and Breast Cancer with Virginia Carnesale  156 / Cell Care with Dr. Monisha Bhanote I've Got Beef With The Health & Wellness Industry | Unfiltered & Unhinged Share the Love: If you found this episode insightful, please share it with a friend, tag us on social media, and leave a review on your favorite podcast platform!

Love the episode? Send us a text!When Breast Cancer Changes Everything — What Do You Build Next?What happens when a breast cancer diagnosis strips away your identity — and forces you to rebuild from the inside out?In this deeply personal and powerful episode of Breast Cancer Conversations, Laura Carfang sits down with Christine Handy and Christine Anastos — two breast cancer survivors who turned trauma into transformation.Christine Handy, former international model and author of Walk Beside Me, opens up about:Undergoing multiple mastectomy surgeriesBreast implant illnessReturning to the runway as a “breastless model”Turning her book into the award-winning film Hello BeautifulReclaiming worth beyond appearanceChristine Anastos (christine@connect-and-thrive.com), environmental engineer and founder of Connect & Thrive (CAT)  shares:Being diagnosed with DCIS while caregiving for her motherCancer's financial toxicity and hidden barriersWhy 90% of breast cancer cases may be environmentally influencedLaunching a public benefit corporation to bridge gaps in survivorship careTogether, these women explore:Identity after a cancer diagnosisFaith and post-traumatic growthThe myth of “doing it alone”Why collaboration is more powerful than competitionWhat it really means to be a “cancer disruptor”Welcome to the conversation. Support the showLatest News: Become a Breast Cancer Conversations+ Member! Sign Up Now. Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources! Enjoying our content? Please consider supporting our work.

What is it like to hear your child tell their cancer story… when you remember every detail they don't?In this powerful Part 2 conversation, the Game Over: c*ncer Podcast sits down with Julie Feuerstein, mom of pediatric cancer survivor Mara, to explore the family side of a childhood leukemia diagnosis. While Mara shared her story in our previous episode, today we hear from the mother who lived every second of it.Julie is an assistant professor at the University of Central Florida and a certified speech-language pathologist. But most importantly, she is Mara's mom. In this episode, she shares what it was like navigating her daughter's B-cell ALL leukemia diagnosis, enduring treatment during COVID isolation, and entering the complicated phase of cancer survivorship.We talk about:• The emotional toll of pediatric cancer on parents and marriage• Living in crisis mode during treatment• The trauma and isolation of COVID-era hospital stays• The role of research in increasing childhood leukemia survival rates• Why continued funding for pediatric cancer research matters• What survivorship really looks like years after treatment ends• Letting survivors define their own identity beyond cancerJulie reflects on the tension between relief and fear in survivorship, the long-term side effects of chemotherapy, and the importance of investing in the next generation of scientists so that childhood cancer can one day be eradicated.Mara's story is proof that research works. But this episode is a reminder that the work is not finished.If you believe in advancing pediatric cancer research, supporting families, and turning fear into courage, this conversation is for you.----------------------------------Connect with Dana: https://www.linkedin.com/in/danaknichols/Connect with Val: https://www.linkedin.com/in/valerie-solomon/Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/----------------------------------Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/

This episode continues our conversation with Olympic gold medalist Scott Hamilton, who overcame childhood health challenges to achieving success in figure skating displays the value of resilience and perseverance. Scott shares his unique story as an adopted child, along with a humorous recollection of an early ice-skating mishap that nearly stopped his career before it even began.⁣⁣Scott is an Olympic Champion, cancer survivor, television broadcaster, motivational speaker, author, husband/father and eternal optimist! During his figure skating career, Hamilton's list of achievements includes his Olympic gold medal, over 70 titles, awards, and honors. In 1990, Hamilton was inducted into the United States Olympic Hall of Fame and in that same year, he became a member of the World Figure Skating⁣ Hall of Fame.⁣⁣⁣Following his mother's passing and his own survival of stage 3 testicular cancer, Hamilton launched the Scott Hamilton CARES Foundation (Cancer Alliance for Research, Education and Survivorship) in 2014, with a mission to improve cancer patient survivorship by supporting world class cancer research and the highest quality patient treatment and care. The same year, he founded the⁣ Scott Hamilton Skating Academy, in partnership with the NHL's Nashville Predators, at Ford Ice Centers in Antioch, Bellevue and Clarksville, TN,⁣ to offer students programs to help them fall in love with ice skating.⁣⁣In a world full of complex cancer treatment decisions, understanding your choices is crucial. We stress the importance of being informed and seeking advice from multiple medical experts to understand the variety of options available. Our discussion touches on the holistic approach to health, including lifestyle changes and the life-changing impact of clean water. Discover how HealingStrong offers hope and support for those facing cancer, with strategies to rebuild the body, renew the soul, and refresh the spirit.  Embracing the idea of cancer as a blessing may seem counter-intuitive, yet can lead to resilience and a deepened faith. Find hope with your own empowering journey, and find your own path to healing and strength.⁣⁣Learn more about Scott HEREHealingStrong's mission is to educate, equip and empower our group leaders and group participants through their journey with cancer or other chronic illnesses, and know there is HOPE. We bring this hope through educational materials, webinars, guest speakers, conferences, community small group support and more.Please take advantage of our FREE resources below to help you along your health and healing journey: Support Group Directory Holistic Curriculum - Participant Guide Support Our Mission - Donate Additional Health Resources Listen to Previous Episodes Website: healingstrong.org

A revisit!!! The Olympics happening right now in Italy 2026 has encouraged us to share this two-part interview with you one more time, to give you a chance to hear it for the first time, listen again and share it with others.This episode features a conversation with Olympic gold medalist Scott Hamilton, who overcame childhood health challenges to achieving success in figure skating displays the value of resilience and perseverance. Scott shares his unique story as an adopted child, along with a humorous recollection of an early ice-skating mishap that nearly stopped his career before it even began.⁣⁣Scott is an Olympic Champion, cancer survivor, television broadcaster, motivational speaker, author, husband/father and eternal optimist! During his figure skating career, Hamilton's list of achievements includes his Olympic gold medal, over 70 titles, awards, and honors. In 1990, Hamilton was inducted into the United States Olympic Hall of Fame and in that same year, he became a member of the World Figure Skating⁣ Hall of Fame.⁣⁣⁣Following his mother's passing and his own survival of stage 3 testicular cancer, Hamilton launched the Scott Hamilton CARES Foundation (Cancer Alliance for Research, Education and Survivorship) in 2014, with a mission to improve cancer patient survivorship by supporting world class cancer research and the highest quality patient treatment and care. The same year, he founded the⁣ Scott Hamilton Skating Academy, in partnership with the NHL's Nashville Predators, at Ford Ice Centers in Antioch, Bellevue and Clarksville, TN,⁣ to offer students programs to help them fall in love with ice skating.⁣⁣Embracing the idea of cancer as a blessing may seem counter-intuitive, yet can lead to resilience and a deepened faith.⁣⁣Learn more about Scott HEREHealingStrong's mission is to educate, equip and empower our group leaders and group participants through their journey with cancer or other chronic illnesses, and know there is HOPE. We bring this hope through educational materials, webinars, guest speakers, conferences, community small group support and more.Please take advantage of our FREE resources below to help you along your health and healing journey: Support Group Directory Holistic Curriculum - Participant Guide Support Our Mission - Donate Additional Health Resources Listen to Previous Episodes Website: healingstrong.org

In this episode, I'm joined by Dr Amy Comander, an expert I've been wanting to bring onto the podcast for a long time.Amy is a breast oncologist, lifestyle medicine physician, and Menopause Society Certified Practitioner based at Massachusetts General Hospital. She is, quite honestly, many people's dream oncologist — someone who truly understands that surviving cancer is about far more than getting through treatment.In this conversation, we start with menopause and ask an important question: what drove a breast oncologist to skill up so deeply in menopause and lifestyle medicine?We explore lifestyle medicine through a menopause-after-cancer lens, discussing what is genuinely supportive, what needs to be personalised, and how to talk about health without placing unrealistic pressure back onto patients.Amy also shares more about the PAVING the Path to Wellness for breast cancer survivors. This program is designed to support breast cancer survivors and those navigating menopause with practical, evidence-based tools.I promise you will walk away loving Amy just as much as I do! Listen and be inspired!Resources & links mentioned in this episode:PAVING a Woman's Path Through Menopause and Beyond

As survivorship increases for most cancers, the rate of uterine cancer survivorship is lower than it was in the 1970s. It's also the sixth most common cause of death among women in the United States. The preferred treatment is a hysterectomy, and young women who want to have children have to choose between becoming infertile or being at a higher risk of recurrence. On this Talk of Iowa, Charity Nebbe speaks with a survivor of endometrial cancer who was able to conceive her first child after undergoing hormonal therapy. Then, Nebbe is joined by a gynecologic oncologist, Dr. Megan McDonald, as well as researcher Kristina Thiel and a Ph.D. candidate in her lab, Katie Colling, who share their research into hormonal therapies.

As we begin new year, here is your reminder: Survivorship is active, not passive. What began as a friendship grew into a shared mission—to care for, educate, and advocate for those facing breast cancer. Thanks Friendship Podcast for inviting us for this empowering conversation. In this episode, Dr. Shabana Dewani and I talk honestly about breast cancer from both sides of the table—as physicians and as humans who walk closely with survivors every day. We are both passionate about: movement and strength training- which rebuilds muscle lost during treatment, improves bone density and reduces fracture risk, lowers fatigue, improves energy, supports metabolic health and reduces risk of recurrence.We discuss prevention, recovery, survivorship, and the often unspoken emotional journey that continues long after treatment ends.This isn't just about medicine.It's about connection, trust, hope, and walking alongside patients with compassion and purpose. We are both grateful to have conversations that elevate awareness and strengthen our community.Dr. Shabana Dewani  is board certified in Medical Oncology, Hematology, and Internal Medicine—and a joy to listen to!  She breaks down the oncology process and important factors when deciding treatment.  You'll be able to hear her passion for helping others ensuring they get the best treatment possible.Stay Connected with Dr. Deepa Halaharvi:TikTok: @breastdoctorInstagram: @drdhalaharviTBCP Instagram: @thebreastcancerpodcastWebsite: https://drdeepahalaharvi.com/YouTube: https://www.youtube.com/@deepahalaharvi5917Instagram: @thebreastcancerpodcast